Study highlights potential of p-tau217 assays in Alzheimer’s clinical trials and diagnosis Post author: Post published:March 14, 2024 Post category:uncategorized The performance of two commercial phospho-tau217 (p-tau217) assays. You Might Also Like Regenerative medicine offers a pathway toward curing type 1 diabetes November 26, 2025 Leveraging CGP and ctDNA for improved cancer outcomes January 16, 2025 Hidden infections may play a key role in driving long COVID symptoms December 10, 2025